Home › Funds › Jones Hill Capital LP › GPCR
Jones Hill Capital LP position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Jones Hill Capital LP reported holding 40,567 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.2M, representing 0.46% of its reported portfolio and ranking #27 among its reported holdings. Jones Hill Capital LP has disclosed GPCR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's GPCR position evolved
Jones Hill Capital LP first disclosed a stake in GPCR in Q1 2026 at 100,593 shares (US$4.8M). Across 2 filings, Jones Hill Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 40,567 shares valued at US$2.2M — a reduction of -60,026 shares quarter over quarter.. Notable position changes include a 60% trim in Q2 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.59K | $4.85M | New |
| Q2 2026 | 40.57K | $2.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K sh · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held GPCR?
Jones Hill Capital LP has disclosed GPCR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Jones Hill Capital LP's current position in GPCR?
As of Q2 2026, Jones Hill Capital LP holds 40.57K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $2.18M, representing 0.46% of its reported portfolio and ranking #27.
Has Jones Hill Capital LP been buying or selling GPCR?
In the latest 13F filing (Q2 2026), Jones Hill Capital LP reduced its position in GPCR.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.